Healthcare: How Doctors Treat Dementia and Lung Cancer Could Be About to Change
Podcast |
Industry Focus
Publisher |
The Motley Fool
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Sep 11, 2019
Episode Duration |
00:20:17

Acadia Pharmaceuticals' dementia-related psychosis trial offers new hope to patients diagnosed with Alzheimer's disease.  Also, results from a lung cancer trial just strengthened Eli Lilly's leadership in precision medicine.

Stocks: ACAD, LLY

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review